OTC Markets OTCQB - Delayed Quote USD
NervGen Pharma Corp. (NGENF)
2.7300
-0.2030
(-6.92%)
At close: June 12 at 8:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NGENF | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.40% | 7.54% | 14.08% |
Upgrades & Downgrades
| Initiated | Industrial Alliance: Speculative Buy | 7/13/2021 |
Related Tickers
CAPR Capricor Therapeutics, Inc.
11.78
-15.49%
ACHV Achieve Life Sciences, Inc.
3.2500
-2.11%
ATYR aTyr Pharma, Inc.
5.20
-4.24%
MDNAF Medicenna Therapeutics Corp.
0.6530
-4.53%
ACXP Acurx Pharmaceuticals, Inc.
0.3050
-7.60%
PHRRF PharmaTher Holdings Ltd.
0.1700
+11.11%
RZLT Rezolute, Inc.
4.2000
-4.55%
DMAC DiaMedica Therapeutics Inc.
3.6500
-6.41%
COYA Coya Therapeutics, Inc.
5.63
+4.84%
CRDF Cardiff Oncology, Inc.
3.8100
+0.53%